The ECMO learning pathway is designed to support perfusionists, nurses, respiratory therapists, and ECMO specialists while developing their approach to using the CentriMag™ Acute Circulatory Support System for ECMO treatment.
We have broken down the ECMO learning pathway into four phases:
In the fourth and final phase, we offer Abbott product information, online publications, and additional online resources that cover clinical outcomes for the CentriMag Circulatory Support System, bridging strategies for ECMO, and more.
Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: a systematic literature review and meta-analysis of observational studies.
Borisenko et al., ASAIO Journal. 2014
Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
Den Uil et al., European Journal of Cardio-Thoracic Surgery. 2017
CentriMag venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory postcardiotomy cardiogenic shock.
Mikus et al., ASAIO Journal. 2013
A systematic review of effectiveness and economic evaluation of Cardiohelp and portable devices for extracorporeal membrane oxygenation.
Mahboub-Ahari et al., Journal of Artificial Organs. 2018
Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional centrimag biventricular configuration.
Takeda et al., European Journal of Cardio-Thoracic Surgery. 2017
Survival on biventricular mechanical support with the CentriMag as a bridge to decision: a single-center risk stratification.
Mohamedali et al., Perfusion. 2015
Venoarterial ECMO for Adults JACC Scientific Expert Panel.
Guglin et al., Journal of the American College of Cardiology. 2019
Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure.
John et al., The Journal of Thoracic and Cardiovascular Surgery. 2007
Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study.
Thomas et al., European Journal of Cardio-Thoracic Surgery. 2011
Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various cases.
Takayama et al., Circulation: Heart Failure. 2014
Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
Urban et al., Interactive Cardiovascular and Thoracic Surgery. 2015
Bridging to lung transplantation with extracorporeal circulatory support: when or when not?
Loor et al., Journal of Thoracic Disease. 2017
Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant: Considerations for Critical Care Nursing Practice.
Koons et al., Critical Care Nurse. 2020
Call the 24-Hour HeartLine: 1 (800) 456-1477
Attend the ELSO Adult ECMO Training Course, which is offered several times per year.
This concludes our ECMO learning pathway. You can review the full ECMO learning pathway or contact Abbott for any questions you have.
MAT-2116880 v3.0
CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.
© 2023 Abbott. All Rights Reserved.
MAT-1900882 v10.0